Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0HZ2A
|
|||
| Former ID |
DIB008833
|
|||
| Drug Name |
Recombinant factor VIIa PEGylated liposomal
|
|||
| Synonyms |
Recombinant factor VIIa; Recombinant factor VIIa (PEGylated liposomal (NecLip), Hemophilia A) Recoly
Click to Show/Hide
|
|||
| Indication | Factor VII deficiency [ICD-11: 3B14; ICD-10: D68.2] | Phase 1/2 | [1] | |
| Company |
Recoly NV
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII--an open label, exploratory, cross-over, phase I/II study. Haemophilia. 2010 Nov;16(6):910-8. | |||
| REF 2 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2363). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.